CH3 BioSystems, LLC

Wickenstones is a full service market access consultancy working with the pharmaceutical, biotech, diagnostic and device sectors.

Founded with two clear objectives:
- Build strong internal alignment for our clients to maximise the value of their assets.
- Overcome the complex and difficult challenges of market access through persistence and innovation.

Our project leaders have over 150 years experience in the healthcare industry and access consulting.

Backgrounds
General management in pharma - Market access leadership across European and global organisations - Medical affairs leadership and experience in top level market access consultancies.

Therapy Areas
Experience from phase I to beyond loss of exclusivity in many therapy areas including oncology – respiratory - mental health – cardiovascular – autoimmune – ophthalmology – vaccines – virology - dermatology & wound care.

Geographical Scope
We have global reach and experience including European markets - The USA – Brazil – Russia – India - China (BRIC) plus other Asian markets.

Reach
We have affiliated staff in the UK, Scandinavia, Italy, Spain, France and Switzerland.

Quality
All our work is underwritten by our commitment to quality.

Epitope Diagnostics, Inc. is an ISO 13845 certified medical device manufacture company located in the Sorrento Valley biotech hub in San Diego. Epitope specializes in development and manufacture of assays for the global medical device and diagnostics industry. Our areas of interest includes gastrointestinal, cardiovascular, infectious and autoimmune disease, as well as tumors/cancers and calcium/bone metabolism.

Founded in 2002, CELPROGEN is a biotechnology company, with over 5000 products in the market, focused on developing stem cell research and therapeutics products for regenerative medicine in cardiology, oncology, diabetes & neurology. All of Celprogen’s biological products, including stem cells, cancer stem cells, iPC’s & media with specific ECM’s, are manufactured and produced in the United States of America.

CELPROGEN provides novel molecular diagnostics and therapeutic product development solutions for Biotechnology, Pharmaceutical, In-vitro diagnostics and academic partnership for drug discovery.

It has 3 divisions:

• Therapeutic Division: Focused on Drug Discovery efforts to develop Pharmaceutical agents and Drugs in the following categories: Cardiovascular, Diabetes, Neurological, Oncology,Renal and Metabolic disorders.
• Life Science Division: Provides research tools & solutions for assays, enzymes, antibodies, antigens, stem cells, Tissue culture expansion and differentiation media, primary and established cell cultures, tumor markers, cardiac markers, proteomic and genomic reagents and assay systems for life science academic and pharmaceutical communities.
• Device Division: Provides novel ELISA based assay, protein array, DNA array and cellular based assay systems that are cost effective for Research and In-vitro diagnostics Industries.

AltheaDx is a commercial stage molecular diagnostics company specializing in the field of pharmacogenetics, or PGx. IDgenetix, our PGx product testing portfolio, enables personalized therapeutic decisions for patients suffering from some of the most prevalent clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders, and pain.

Aviva Systems Biology specializes in providing polyclonal and monoclonal antibodies, ELISA kits, proteins, and custom services for research needs. We manufacture 24,000 validated polyclonal antibodies and offer nearly 20,000 ELISA kits. Our custom laboratory services include protein expression and purification, antibody development, and ELISA development, validation, and production.

Our head office is in San Diego, CA, we also have an office in Beijing, China. Both locations provide scientific support assisting researchers with a variety of proteomic objectives.

Aviva provides unique tools for research associated to unique species and targets. The company's products are relevant to 10,000 unique species, 10,000 cellular processes, and 5,000 protein pathways.

Research Areas
Transcription factors, cancer, cardiovascular, cell biology, DNA damage and repair, epigenetics, signal transduction, cell differentiation, stem cell biology , and many more.

Specialties
Western blot, immunohistochemistry, ELISA, custom protein expression